CEO SUMMARY: It is time for pathologists and cytologists to buckle their safety belts. The marketplace for automated cytology is entering a new cycle of rapid change. NeoPath’s AutoPap System is now poised to demonstrate that it is economical and clinically viable. Expect continual improvements to automated cytology technology to eventually replace traditional methods of […]
AutoPap System Cleared For Primary Screening
Neopath’s automated cytology technology is first of more cytology products to follow
- By Robert Michel
- > From the Volume V No. 7 - May 26, 1998 Issue
